An interleukin 12-related cytokine is up-regulated in ulcerative colitis but not in Crohn's disease

被引:61
作者
Christ, AD
Stevens, AC
Koeppen, H
Walsh, S
Omata, F
Devergne, O
Birkenbach, M
Blumberg, RS
机构
[1] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Gastroenterol, Boston, MA 02115 USA
[2] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Infect Dis, Boston, MA 02115 USA
[3] Harvard Univ, Beth Israel Hosp, Sch Med, Div Gastroenterol, Boston, MA 02115 USA
[4] Harvard Univ, Beth Israel Hosp, Sch Med, Dept Pathol, Boston, MA 02115 USA
[5] Univ Chicago, Dept Pathol, Chicago, IL 60637 USA
关键词
D O I
10.1016/S0016-5085(98)70197-0
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background & Aims: interleukin 12 (IL-12) is a heterodimeric, macrophage-derived cytokine that is elevated in Crohn's disease (CD). Epstein-Barr virus-induced gene 3 (EBI3) is a recently characterized human glycoprotein that is homologous to the 40-kilodalton chain of IL-12 and forms a heterodimer with the 35-kilodalton chain of IL-12. We investigated the expression of EBI3 in colonic mucosa of normal control subjects, patients with ulcerative colitis (UC), and patients with CD. Methods: Colonic tissue was analyzed for messenger RNA (mRNA) expression by quantitative polymerase chain reaction and for protein expression by immunohistology and Western blotting. Results: EBI3 mRNA was present in intestinal biopsy specimens from healthy subjects and patients with CD but was elevated only in active UC. EBI3 levels in UC specimens correlated with histological scores of activity and T-cell infiltration. EBI3-positive cells that had a shape consistent with that of macrophages were identified in the lamina propria, and protein was detected by Western blotting. Conclusions: EBI3 is a novel IL-12-related cytokine that is expressed by macrophage-like cells in normal intestine and CD and has enhanced expression in active UC but not in active CD.
引用
收藏
页码:307 / 313
页数:7
相关论文
共 33 条
  • [1] BARBER GB, 1985, AM J GASTROENTEROL, V80, P612
  • [2] CASINIRAGGI V, 1995, J IMMUNOL, V154, P2434
  • [3] Chott A, 1996, J IMMUNOL, V156, P3024
  • [4] Distinct cytokine patterns in early and chronic ileal lesions of Crohn's disease
    Desreumaux, P
    Brandt, E
    Gambiez, L
    Emilie, D
    Geboes, K
    Klein, O
    Ectors, N
    Cortot, A
    Capron, M
    Colombel, JF
    [J]. GASTROENTEROLOGY, 1997, 113 (01) : 118 - 126
  • [5] A novel interleukin-12 p40-related protein induced by latent Epstein-Barr virus infection in B lymphocytes
    Devergne, O
    Hummel, M
    Koeppen, H
    LeBeau, MM
    Nathanson, EC
    Kieff, E
    Birkenbach, M
    [J]. JOURNAL OF VIROLOGY, 1996, 70 (02) : 1143 - 1153
  • [6] Epstein-Barr virus-induced gene 3 and the p35 subunit of interleukin 12 form a novel heterodimeric hematopoietin
    Devergne, O
    Birkenbach, M
    Kieff, E
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (22) : 12041 - 12046
  • [7] Tolerance towards resident intestinal flora in mice is abrogated in experimental colitis and restored by treatment with interleukin-10 or antibodies to interleukin-12
    Duchmann, R
    Schmitt, E
    Knolle, P
    zumBuschenfelde, KHM
    Neurath, M
    [J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 1996, 26 (04) : 934 - 938
  • [8] CYTOKINES AND ANIMAL-MODELS - A COMBINED PATH TO INFLAMMATORY BOWEL-DISEASE PATHOGENESIS
    FIOCCHI, C
    [J]. GASTROENTEROLOGY, 1993, 104 (04) : 1202 - 1205
  • [9] Fuss IJ, 1996, J IMMUNOL, V157, P1261
  • [10] MOUSE INTERLEUKIN-12 (IL-12) P40 HOMODIMER - A POTENT IL-12 ANTAGONIST
    GILLESSEN, S
    CARVAJAL, D
    LING, P
    PODLASKI, FJ
    STREMLO, DL
    FAMILLETTI, PC
    GUBLER, U
    PRESKY, DH
    STERN, AS
    GATELY, MK
    [J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 1995, 25 (01) : 200 - 206